HCA Healthcare (NYSE:HCA) Price Target Raised to $396.00 at SVB Leerink

HCA Healthcare (NYSE:HCA) had its price objective increased by SVB Leerink from $367.00 to $396.00 in a research report report published on Wednesday morning, Benzinga reports. SVB Leerink currently has an outperform rating on the stock.

Several other equities analysts also recently weighed in on the company. Barclays lifted their target price on HCA Healthcare from $367.00 to $376.00 and gave the company an overweight rating in a research report on Wednesday, July 10th. Truist Financial raised their price target on HCA Healthcare from $375.00 to $390.00 and gave the company a buy rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a buy rating in a report on Friday, June 28th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $327.00 to $332.00 and gave the company a neutral rating in a report on Thursday, May 30th. Finally, TD Cowen decreased their price target on HCA Healthcare from $371.00 to $360.00 and set a buy rating on the stock in a report on Tuesday, April 30th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of Moderate Buy and a consensus price target of $339.72.

HCA Healthcare Stock Performance

HCA stock opened at $354.78 on Wednesday. The company has a market cap of $92.92 billion, a P/E ratio of 17.69, a price-to-earnings-growth ratio of 1.38 and a beta of 1.68. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $356.30. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 1.02. The stock’s fifty day moving average price is $330.12 and its 200-day moving average price is $323.02.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $4.29 earnings per share. On average, equities analysts forecast that HCA Healthcare will post 22.38 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock worth $3,921,929 over the last ninety days. Company insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust boosted its position in HCA Healthcare by 8.2% during the 4th quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after acquiring an additional 35 shares in the last quarter. FinTrust Capital Advisors LLC lifted its holdings in shares of HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the last quarter. Financial Counselors Inc. lifted its holdings in shares of HCA Healthcare by 1.4% during the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after purchasing an additional 36 shares during the last quarter. Premier Path Wealth Partners LLC lifted its holdings in shares of HCA Healthcare by 2.7% during the 2nd quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after purchasing an additional 36 shares during the last quarter. Finally, Westside Investment Management Inc. lifted its holdings in shares of HCA Healthcare by 14.7% during the 2nd quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after purchasing an additional 37 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.